NAD+ Therapy for Anti-Aging: Does It Really Work? (2026 Science Review)

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every cell in your body. It's essential for cellular energy production (ATP generation), DNA repair, and activating sirtuins — proteins that regulate cellular health and longevity. NAD+ levels decline naturally with age, dropping by approximately 50% between age 20 and 60. This decline is associated with many hallmarks of aging: reduced energy, impaired DNA repair, mitochondrial dysfunction, and increased inflammation. The theory behind NAD+ supplementation is that restoring youthful NAD+ levels may slow or reverse some aspects of cellular aging.

The evidence is promising but preliminary. Human studies show NAD+ precursors (NMN and NR) increase blood NAD+ levels by 40-90%. Some small human trials (under 100 participants) report improvements in muscle function, insulin sensitivity, and cognitive performance. However, no long-term human studies have demonstrated that NAD+ supplementation extends lifespan or prevents age-related disease. Most of the lifespan extension evidence comes from animal studies (mice, worms, yeast). The field is moving fast — over 50 clinical trials are currently registered for NAD+ precursors. For now, the evidence supports NAD+ therapy for energy and cellular health, but claims about reversing aging are speculative.

NAD+ injections (prescription, self-administered): highest bioavailability, most expensive ($100-200/month), requires prescription. IV NAD+ therapy (clinic-administered): highest blood levels achievable, most expensive ($500-1,000+ per session), requires clinic visit. Oral NAD+ precursors (NMN, NR, niacin): affordable ($30-60/month), variable absorption, some brands have questionable quality. A 2022 study in Nature Communications found that oral NR increased NAD+ levels by 60% at 1g/day. Injections and IV achieve higher peak levels but oral precursors are more practical for long-term use. Strut Health offers prescription NAD+ injections starting at $103/month.

NAD+ therapy is generally well-tolerated. Common side effects are mild: flushing (especially with niacin), nausea, headache, and fatigue in the first few days. IV therapy can cause more pronounced side effects during infusion: dizziness, nausea at the injection site, and vein irritation. Long-term safety data beyond 12 months is limited. People with active cancer should not take NAD+ precursors without consulting their oncologist — some studies suggest NAD+ may promote tumor growth, though this is debated. Always consult a physician before starting NAD+ therapy.

NAD+ therapy is most commonly considered by: adults over 40 experiencing age-related energy decline or brain fog, biohackers and longevity enthusiasts seeking to optimize cellular health, athletes looking for improved recovery and endurance, and people interested in preventive anti-aging strategies. It's less appropriate for: people under 30 with naturally high NAD+ levels (supplementation shows minimal benefit), those with active cancer diagnoses (theoretical risk), and people on a tight budget (oral NMN/NR is cheaper than injections). Strut Health's NAD+ program is available through their telemedicine platform with a physician consultation included.